Updated:
MedeAnalytics
MedeAnalytics unifies payer data and applies AI to prioritize the highest-ROI cost and quality interventions for health plans and risk-bearing...
MedeAnalytics
MedeAnalytics operates as a healthcare performance-improvement company from its headquarters in Richardson, Texas. The firm specializes in unifying fragmented payer data and applying AI to identify, predict, and prioritize cost, quality, and risk opportunities across commercial, Medicare Advantage, and Medicaid lines of business. Its core thesis argues that dashboards alone fail to improve medical-loss ratios or Star ratings; organizations need machine-driven workflows that sequence actions by financial impact. The platform addresses a defined set of operational levers: MLR and administrative-cost reduction, HEDIS and Stars gap closure, specialty-pharmacy and utilization management, provider-network performance optimization, and value-based contract operationalization. Specific capabilities include predicting high-cost claimants, quantifying unnecessary inpatient and outpatient utilization, and automating member-outreach playbooks. The firm’s Health Fabric™ data foundation integrates cross-domain information — enrollment, claims, SDOH, risk scores — to feed AI models and agentic workflows that the firm brands as Managed Action™. In September 2024, the firm published research quantifying the retention economics of Medicare Advantage, noting that 15.6 percent of members switched plans within one year and that sub-4-Star performance forfeits Quality Bonus Payments averaging roughly 5 percent of federal revenue. MedeAnalytics does not publicly disclose investor backing, AUM, headcount, or named principals, and no adjacent investment vehicles, philanthropic foundations, or co-investment clubs are evident in its materials. Structurally, MedeAnalytics distinguishes itself by coupling enterprise analytics with embedded accountability. Rather than delivering a dashboard and exiting, the firm layers on strategic advisory resources and Agentic AI-driven playbooks that execute prioritized actions — a model that attempts to collapse the distance between insight and measurable payer-performance improvement, turning a analytics vendor into an operational improvement partner.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Richardson
Corporate office
501 W President George Bush Highway, Suite 250, Richardson, TX 75080, United States
Sector focus
Frequently asked questions
What does MedeAnalytics actually do for health plans?
It ingests and unifies data across claims, enrollment, quality, and social determinants of health, then applies AI to predict and prioritize the highest-return cost and quality actions — such as which members to target for HEDIS gap closure or which utilization patterns are driving MLR deterioration. The platform packages those priorities into automated workflows and playbooks. MedeAnalytics positions its output as accountable action rather than passive dashboards.
How does MedeAnalytics target medical-loss ratio improvement?
The platform isolates medical-cost drivers by condition, cohort, provider, and site of care, then quantifies the margin impact of each. It surfaces avoidable utilization across inpatient, outpatient, and pharmacy spend, and predicts high-cost claimants before episodes occur. Those signals feed targeted initiatives that payers can deploy to measurably reduce MLR and administrative cost.
Does MedeAnalytics function purely as a software vendor?
No. The firm pairs its AI-driven platform with embedded Strategic Advisors who assist in accelerating performance improvement. Its architecture includes Agentic AI and Managed Action™ workflows that operationalize the insights, making it a hybrid analytics-plus-execution offering rather than a standalone software license.
Which lines of business does MedeAnalytics serve?
The firm works across commercial, Medicare Advantage, and Medicaid lines, with publicly cited expertise in employer-group performance reporting, Stars and HEDIS management, value-based contract operationalization, and network-performance optimization. Its marketing emphasizes performance measurement for risk-bearing entities broadly.
Is MedeAnalytics backed by private equity or venture capital?
No public funding source is disclosed. The firm does not publish investors, ownership structure, or capitalization details through its corporate website or other accessible primary sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: